Global Pet Medication Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Pet Medication Industry Forecast” looks at past sales and reviews total world Pet Medication sales in 2022, providing a comprehensive analysis by region and market sector of projected Pet Medication sales for 2023 through 2029. With Pet Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Medication industry.
This Insight Report provides a comprehensive analysis of the global Pet Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pet Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Medication and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Medication.
The global Pet Medication market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pet Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pet Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pet Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pet Medication players cover Zoetis, Merck, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva and Vetoquinol, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Medication market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pet Medication market?
What factors are driving Pet Medication market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Medication market opportunities vary by end market size?
How does Pet Medication break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Pet Medication Industry Forecast” looks at past sales and reviews total world Pet Medication sales in 2022, providing a comprehensive analysis by region and market sector of projected Pet Medication sales for 2023 through 2029. With Pet Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Medication industry.
This Insight Report provides a comprehensive analysis of the global Pet Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pet Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Medication and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Medication.
The global Pet Medication market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pet Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pet Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pet Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pet Medication players cover Zoetis, Merck, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva and Vetoquinol, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Medication market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Antibiotics
- Antifungal
- Flea Products
- Cat
- Dog
- Horse
- Fish
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Merck
- Elanco
- Bayer
- Boehringer
- Novartis
- Virbac
- Ceva
- Vetoquinol
- Nexvet
- Aratana Therapeutics
- Kindred Biosciences
- Ambrx
- Entest Biomedical
- Taconic Biosciences
What is the 10-year outlook for the global Pet Medication market?
What factors are driving Pet Medication market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Medication market opportunities vary by end market size?
How does Pet Medication break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet Medication Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pet Medication by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pet Medication by Country/Region, 2018, 2022 & 2029
2.2 Pet Medication Segment by Type
2.2.1 Antibiotics
2.2.2 Antifungal
2.2.3 Flea Products
2.3 Pet Medication Sales by Type
2.3.1 Global Pet Medication Sales Market Share by Type (2018-2023)
2.3.2 Global Pet Medication Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pet Medication Sale Price by Type (2018-2023)
2.4 Pet Medication Segment by Application
2.4.1 Cat
2.4.2 Dog
2.4.3 Horse
2.4.4 Fish
2.4.5 Others
2.5 Pet Medication Sales by Application
2.5.1 Global Pet Medication Sale Market Share by Application (2018-2023)
2.5.2 Global Pet Medication Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pet Medication Sale Price by Application (2018-2023)
3 GLOBAL PET MEDICATION BY COMPANY
3.1 Global Pet Medication Breakdown Data by Company
3.1.1 Global Pet Medication Annual Sales by Company (2018-2023)
3.1.2 Global Pet Medication Sales Market Share by Company (2018-2023)
3.2 Global Pet Medication Annual Revenue by Company (2018-2023)
3.2.1 Global Pet Medication Revenue by Company (2018-2023)
3.2.2 Global Pet Medication Revenue Market Share by Company (2018-2023)
3.3 Global Pet Medication Sale Price by Company
3.4 Key Manufacturers Pet Medication Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Medication Product Location Distribution
3.4.2 Players Pet Medication Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PET MEDICATION BY GEOGRAPHIC REGION
4.1 World Historic Pet Medication Market Size by Geographic Region (2018-2023)
4.1.1 Global Pet Medication Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pet Medication Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pet Medication Market Size by Country/Region (2018-2023)
4.2.1 Global Pet Medication Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pet Medication Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pet Medication Sales Growth
4.4 APAC Pet Medication Sales Growth
4.5 Europe Pet Medication Sales Growth
4.6 Middle East & Africa Pet Medication Sales Growth
5 AMERICAS
5.1 Americas Pet Medication Sales by Country
5.1.1 Americas Pet Medication Sales by Country (2018-2023)
5.1.2 Americas Pet Medication Revenue by Country (2018-2023)
5.2 Americas Pet Medication Sales by Type
5.3 Americas Pet Medication Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Medication Sales by Region
6.1.1 APAC Pet Medication Sales by Region (2018-2023)
6.1.2 APAC Pet Medication Revenue by Region (2018-2023)
6.2 APAC Pet Medication Sales by Type
6.3 APAC Pet Medication Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet Medication by Country
7.1.1 Europe Pet Medication Sales by Country (2018-2023)
7.1.2 Europe Pet Medication Revenue by Country (2018-2023)
7.2 Europe Pet Medication Sales by Type
7.3 Europe Pet Medication Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet Medication by Country
8.1.1 Middle East & Africa Pet Medication Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pet Medication Revenue by Country (2018-2023)
8.2 Middle East & Africa Pet Medication Sales by Type
8.3 Middle East & Africa Pet Medication Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Medication
10.3 Manufacturing Process Analysis of Pet Medication
10.4 Industry Chain Structure of Pet Medication
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Medication Distributors
11.3 Pet Medication Customer
12 WORLD FORECAST REVIEW FOR PET MEDICATION BY GEOGRAPHIC REGION
12.1 Global Pet Medication Market Size Forecast by Region
12.1.1 Global Pet Medication Forecast by Region (2024-2029)
12.1.2 Global Pet Medication Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Medication Forecast by Type
12.7 Global Pet Medication Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Pet Medication Product Portfolios and Specifications
13.1.3 Zoetis Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Pet Medication Product Portfolios and Specifications
13.2.3 Merck Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Elanco
13.3.1 Elanco Company Information
13.3.2 Elanco Pet Medication Product Portfolios and Specifications
13.3.3 Elanco Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Elanco Main Business Overview
13.3.5 Elanco Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Pet Medication Product Portfolios and Specifications
13.4.3 Bayer Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Boehringer
13.5.1 Boehringer Company Information
13.5.2 Boehringer Pet Medication Product Portfolios and Specifications
13.5.3 Boehringer Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Boehringer Main Business Overview
13.5.5 Boehringer Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Pet Medication Product Portfolios and Specifications
13.6.3 Novartis Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Virbac
13.7.1 Virbac Company Information
13.7.2 Virbac Pet Medication Product Portfolios and Specifications
13.7.3 Virbac Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Virbac Main Business Overview
13.7.5 Virbac Latest Developments
13.8 Ceva
13.8.1 Ceva Company Information
13.8.2 Ceva Pet Medication Product Portfolios and Specifications
13.8.3 Ceva Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Ceva Main Business Overview
13.8.5 Ceva Latest Developments
13.9 Vetoquinol
13.9.1 Vetoquinol Company Information
13.9.2 Vetoquinol Pet Medication Product Portfolios and Specifications
13.9.3 Vetoquinol Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Vetoquinol Main Business Overview
13.9.5 Vetoquinol Latest Developments
13.10 Nexvet
13.10.1 Nexvet Company Information
13.10.2 Nexvet Pet Medication Product Portfolios and Specifications
13.10.3 Nexvet Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nexvet Main Business Overview
13.10.5 Nexvet Latest Developments
13.11 Aratana Therapeutics
13.11.1 Aratana Therapeutics Company Information
13.11.2 Aratana Therapeutics Pet Medication Product Portfolios and Specifications
13.11.3 Aratana Therapeutics Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Aratana Therapeutics Main Business Overview
13.11.5 Aratana Therapeutics Latest Developments
13.12 Kindred Biosciences
13.12.1 Kindred Biosciences Company Information
13.12.2 Kindred Biosciences Pet Medication Product Portfolios and Specifications
13.12.3 Kindred Biosciences Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Kindred Biosciences Main Business Overview
13.12.5 Kindred Biosciences Latest Developments
13.13 Ambrx
13.13.1 Ambrx Company Information
13.13.2 Ambrx Pet Medication Product Portfolios and Specifications
13.13.3 Ambrx Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Ambrx Main Business Overview
13.13.5 Ambrx Latest Developments
13.14 Entest Biomedical
13.14.1 Entest Biomedical Company Information
13.14.2 Entest Biomedical Pet Medication Product Portfolios and Specifications
13.14.3 Entest Biomedical Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Entest Biomedical Main Business Overview
13.14.5 Entest Biomedical Latest Developments
13.15 Taconic Biosciences
13.15.1 Taconic Biosciences Company Information
13.15.2 Taconic Biosciences Pet Medication Product Portfolios and Specifications
13.15.3 Taconic Biosciences Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Taconic Biosciences Main Business Overview
13.15.5 Taconic Biosciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet Medication Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pet Medication by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pet Medication by Country/Region, 2018, 2022 & 2029
2.2 Pet Medication Segment by Type
2.2.1 Antibiotics
2.2.2 Antifungal
2.2.3 Flea Products
2.3 Pet Medication Sales by Type
2.3.1 Global Pet Medication Sales Market Share by Type (2018-2023)
2.3.2 Global Pet Medication Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pet Medication Sale Price by Type (2018-2023)
2.4 Pet Medication Segment by Application
2.4.1 Cat
2.4.2 Dog
2.4.3 Horse
2.4.4 Fish
2.4.5 Others
2.5 Pet Medication Sales by Application
2.5.1 Global Pet Medication Sale Market Share by Application (2018-2023)
2.5.2 Global Pet Medication Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pet Medication Sale Price by Application (2018-2023)
3 GLOBAL PET MEDICATION BY COMPANY
3.1 Global Pet Medication Breakdown Data by Company
3.1.1 Global Pet Medication Annual Sales by Company (2018-2023)
3.1.2 Global Pet Medication Sales Market Share by Company (2018-2023)
3.2 Global Pet Medication Annual Revenue by Company (2018-2023)
3.2.1 Global Pet Medication Revenue by Company (2018-2023)
3.2.2 Global Pet Medication Revenue Market Share by Company (2018-2023)
3.3 Global Pet Medication Sale Price by Company
3.4 Key Manufacturers Pet Medication Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Medication Product Location Distribution
3.4.2 Players Pet Medication Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PET MEDICATION BY GEOGRAPHIC REGION
4.1 World Historic Pet Medication Market Size by Geographic Region (2018-2023)
4.1.1 Global Pet Medication Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pet Medication Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pet Medication Market Size by Country/Region (2018-2023)
4.2.1 Global Pet Medication Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pet Medication Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pet Medication Sales Growth
4.4 APAC Pet Medication Sales Growth
4.5 Europe Pet Medication Sales Growth
4.6 Middle East & Africa Pet Medication Sales Growth
5 AMERICAS
5.1 Americas Pet Medication Sales by Country
5.1.1 Americas Pet Medication Sales by Country (2018-2023)
5.1.2 Americas Pet Medication Revenue by Country (2018-2023)
5.2 Americas Pet Medication Sales by Type
5.3 Americas Pet Medication Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Medication Sales by Region
6.1.1 APAC Pet Medication Sales by Region (2018-2023)
6.1.2 APAC Pet Medication Revenue by Region (2018-2023)
6.2 APAC Pet Medication Sales by Type
6.3 APAC Pet Medication Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet Medication by Country
7.1.1 Europe Pet Medication Sales by Country (2018-2023)
7.1.2 Europe Pet Medication Revenue by Country (2018-2023)
7.2 Europe Pet Medication Sales by Type
7.3 Europe Pet Medication Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet Medication by Country
8.1.1 Middle East & Africa Pet Medication Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pet Medication Revenue by Country (2018-2023)
8.2 Middle East & Africa Pet Medication Sales by Type
8.3 Middle East & Africa Pet Medication Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Medication
10.3 Manufacturing Process Analysis of Pet Medication
10.4 Industry Chain Structure of Pet Medication
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Medication Distributors
11.3 Pet Medication Customer
12 WORLD FORECAST REVIEW FOR PET MEDICATION BY GEOGRAPHIC REGION
12.1 Global Pet Medication Market Size Forecast by Region
12.1.1 Global Pet Medication Forecast by Region (2024-2029)
12.1.2 Global Pet Medication Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Medication Forecast by Type
12.7 Global Pet Medication Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Pet Medication Product Portfolios and Specifications
13.1.3 Zoetis Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Pet Medication Product Portfolios and Specifications
13.2.3 Merck Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Elanco
13.3.1 Elanco Company Information
13.3.2 Elanco Pet Medication Product Portfolios and Specifications
13.3.3 Elanco Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Elanco Main Business Overview
13.3.5 Elanco Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Pet Medication Product Portfolios and Specifications
13.4.3 Bayer Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Boehringer
13.5.1 Boehringer Company Information
13.5.2 Boehringer Pet Medication Product Portfolios and Specifications
13.5.3 Boehringer Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Boehringer Main Business Overview
13.5.5 Boehringer Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Pet Medication Product Portfolios and Specifications
13.6.3 Novartis Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Virbac
13.7.1 Virbac Company Information
13.7.2 Virbac Pet Medication Product Portfolios and Specifications
13.7.3 Virbac Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Virbac Main Business Overview
13.7.5 Virbac Latest Developments
13.8 Ceva
13.8.1 Ceva Company Information
13.8.2 Ceva Pet Medication Product Portfolios and Specifications
13.8.3 Ceva Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Ceva Main Business Overview
13.8.5 Ceva Latest Developments
13.9 Vetoquinol
13.9.1 Vetoquinol Company Information
13.9.2 Vetoquinol Pet Medication Product Portfolios and Specifications
13.9.3 Vetoquinol Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Vetoquinol Main Business Overview
13.9.5 Vetoquinol Latest Developments
13.10 Nexvet
13.10.1 Nexvet Company Information
13.10.2 Nexvet Pet Medication Product Portfolios and Specifications
13.10.3 Nexvet Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nexvet Main Business Overview
13.10.5 Nexvet Latest Developments
13.11 Aratana Therapeutics
13.11.1 Aratana Therapeutics Company Information
13.11.2 Aratana Therapeutics Pet Medication Product Portfolios and Specifications
13.11.3 Aratana Therapeutics Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Aratana Therapeutics Main Business Overview
13.11.5 Aratana Therapeutics Latest Developments
13.12 Kindred Biosciences
13.12.1 Kindred Biosciences Company Information
13.12.2 Kindred Biosciences Pet Medication Product Portfolios and Specifications
13.12.3 Kindred Biosciences Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Kindred Biosciences Main Business Overview
13.12.5 Kindred Biosciences Latest Developments
13.13 Ambrx
13.13.1 Ambrx Company Information
13.13.2 Ambrx Pet Medication Product Portfolios and Specifications
13.13.3 Ambrx Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Ambrx Main Business Overview
13.13.5 Ambrx Latest Developments
13.14 Entest Biomedical
13.14.1 Entest Biomedical Company Information
13.14.2 Entest Biomedical Pet Medication Product Portfolios and Specifications
13.14.3 Entest Biomedical Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Entest Biomedical Main Business Overview
13.14.5 Entest Biomedical Latest Developments
13.15 Taconic Biosciences
13.15.1 Taconic Biosciences Company Information
13.15.2 Taconic Biosciences Pet Medication Product Portfolios and Specifications
13.15.3 Taconic Biosciences Pet Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Taconic Biosciences Main Business Overview
13.15.5 Taconic Biosciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pet Medication Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pet Medication Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Antibiotics
Table 4. Major Players of Antifungal
Table 5. Major Players of Flea Products
Table 6. Global Pet Medication Sales by Type (2018-2023) & (K MT)
Table 7. Global Pet Medication Sales Market Share by Type (2018-2023)
Table 8. Global Pet Medication Revenue by Type (2018-2023) & ($ million)
Table 9. Global Pet Medication Revenue Market Share by Type (2018-2023)
Table 10. Global Pet Medication Sale Price by Type (2018-2023) & (USD/MT)
Table 11. Global Pet Medication Sales by Application (2018-2023) & (K MT)
Table 12. Global Pet Medication Sales Market Share by Application (2018-2023)
Table 13. Global Pet Medication Revenue by Application (2018-2023)
Table 14. Global Pet Medication Revenue Market Share by Application (2018-2023)
Table 15. Global Pet Medication Sale Price by Application (2018-2023) & (USD/MT)
Table 16. Global Pet Medication Sales by Company (2018-2023) & (K MT)
Table 17. Global Pet Medication Sales Market Share by Company (2018-2023)
Table 18. Global Pet Medication Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Pet Medication Revenue Market Share by Company (2018-2023)
Table 20. Global Pet Medication Sale Price by Company (2018-2023) & (USD/MT)
Table 21. Key Manufacturers Pet Medication Producing Area Distribution and Sales Area
Table 22. Players Pet Medication Products Offered
Table 23. Pet Medication Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pet Medication Sales by Geographic Region (2018-2023) & (K MT)
Table 27. Global Pet Medication Sales Market Share Geographic Region (2018-2023)
Table 28. Global Pet Medication Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Pet Medication Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Pet Medication Sales by Country/Region (2018-2023) & (K MT)
Table 31. Global Pet Medication Sales Market Share by Country/Region (2018-2023)
Table 32. Global Pet Medication Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Pet Medication Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Pet Medication Sales by Country (2018-2023) & (K MT)
Table 35. Americas Pet Medication Sales Market Share by Country (2018-2023)
Table 36. Americas Pet Medication Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Pet Medication Revenue Market Share by Country (2018-2023)
Table 38. Americas Pet Medication Sales by Type (2018-2023) & (K MT)
Table 39. Americas Pet Medication Sales by Application (2018-2023) & (K MT)
Table 40. APAC Pet Medication Sales by Region (2018-2023) & (K MT)
Table 41. APAC Pet Medication Sales Market Share by Region (2018-2023)
Table 42. APAC Pet Medication Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Pet Medication Revenue Market Share by Region (2018-2023)
Table 44. APAC Pet Medication Sales by Type (2018-2023) & (K MT)
Table 45. APAC Pet Medication Sales by Application (2018-2023) & (K MT)
Table 46. Europe Pet Medication Sales by Country (2018-2023) & (K MT)
Table 47. Europe Pet Medication Sales Market Share by Country (2018-2023)
Table 48. Europe Pet Medication Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Pet Medication Revenue Market Share by Country (2018-2023)
Table 50. Europe Pet Medication Sales by Type (2018-2023) & (K MT)
Table 51. Europe Pet Medication Sales by Application (2018-2023) & (K MT)
Table 52. Middle East & Africa Pet Medication Sales by Country (2018-2023) & (K MT)
Table 53. Middle East & Africa Pet Medication Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Pet Medication Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Pet Medication Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pet Medication Sales by Type (2018-2023) & (K MT)
Table 57. Middle East & Africa Pet Medication Sales by Application (2018-2023) & (K MT)
Table 58. Key Market Drivers & Growth Opportunities of Pet Medication
Table 59. Key Market Challenges & Risks of Pet Medication
Table 60. Key Industry Trends of Pet Medication
Table 61. Pet Medication Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Pet Medication Distributors List
Table 64. Pet Medication Customer List
Table 65. Global Pet Medication Sales Forecast by Region (2024-2029) & (K MT)
Table 66. Global Pet Medication Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Pet Medication Sales Forecast by Country (2024-2029) & (K MT)
Table 68. Americas Pet Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Pet Medication Sales Forecast by Region (2024-2029) & (K MT)
Table 70. APAC Pet Medication Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Pet Medication Sales Forecast by Country (2024-2029) & (K MT)
Table 72. Europe Pet Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Pet Medication Sales Forecast by Country (2024-2029) & (K MT)
Table 74. Middle East & Africa Pet Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Pet Medication Sales Forecast by Type (2024-2029) & (K MT)
Table 76. Global Pet Medication Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Pet Medication Sales Forecast by Application (2024-2029) & (K MT)
Table 78. Global Pet Medication Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Zoetis Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 80. Zoetis Pet Medication Product Portfolios and Specifications
Table 81. Zoetis Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Zoetis Main Business
Table 83. Zoetis Latest Developments
Table 84. Merck Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Pet Medication Product Portfolios and Specifications
Table 86. Merck Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Elanco Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 90. Elanco Pet Medication Product Portfolios and Specifications
Table 91. Elanco Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Elanco Main Business
Table 93. Elanco Latest Developments
Table 94. Bayer Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer Pet Medication Product Portfolios and Specifications
Table 96. Bayer Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Bayer Main Business
Table 98. Bayer Latest Developments
Table 99. Boehringer Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 100. Boehringer Pet Medication Product Portfolios and Specifications
Table 101. Boehringer Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Boehringer Main Business
Table 103. Boehringer Latest Developments
Table 104. Novartis Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 105. Novartis Pet Medication Product Portfolios and Specifications
Table 106. Novartis Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Novartis Main Business
Table 108. Novartis Latest Developments
Table 109. Virbac Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 110. Virbac Pet Medication Product Portfolios and Specifications
Table 111. Virbac Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Virbac Main Business
Table 113. Virbac Latest Developments
Table 114. Ceva Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 115. Ceva Pet Medication Product Portfolios and Specifications
Table 116. Ceva Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Ceva Main Business
Table 118. Ceva Latest Developments
Table 119. Vetoquinol Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 120. Vetoquinol Pet Medication Product Portfolios and Specifications
Table 121. Vetoquinol Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Vetoquinol Main Business
Table 123. Vetoquinol Latest Developments
Table 124. Nexvet Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 125. Nexvet Pet Medication Product Portfolios and Specifications
Table 126. Nexvet Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. Nexvet Main Business
Table 128. Nexvet Latest Developments
Table 129. Aratana Therapeutics Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 130. Aratana Therapeutics Pet Medication Product Portfolios and Specifications
Table 131. Aratana Therapeutics Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 132. Aratana Therapeutics Main Business
Table 133. Aratana Therapeutics Latest Developments
Table 134. Kindred Biosciences Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 135. Kindred Biosciences Pet Medication Product Portfolios and Specifications
Table 136. Kindred Biosciences Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 137. Kindred Biosciences Main Business
Table 138. Kindred Biosciences Latest Developments
Table 139. Ambrx Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 140. Ambrx Pet Medication Product Portfolios and Specifications
Table 141. Ambrx Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 142. Ambrx Main Business
Table 143. Ambrx Latest Developments
Table 144. Entest Biomedical Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 145. Entest Biomedical Pet Medication Product Portfolios and Specifications
Table 146. Entest Biomedical Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 147. Entest Biomedical Main Business
Table 148. Entest Biomedical Latest Developments
Table 149. Taconic Biosciences Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 150. Taconic Biosciences Pet Medication Product Portfolios and Specifications
Table 151. Taconic Biosciences Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 152. Taconic Biosciences Main Business
Table 153. Taconic Biosciences Latest Developments
Table 1. Pet Medication Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pet Medication Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Antibiotics
Table 4. Major Players of Antifungal
Table 5. Major Players of Flea Products
Table 6. Global Pet Medication Sales by Type (2018-2023) & (K MT)
Table 7. Global Pet Medication Sales Market Share by Type (2018-2023)
Table 8. Global Pet Medication Revenue by Type (2018-2023) & ($ million)
Table 9. Global Pet Medication Revenue Market Share by Type (2018-2023)
Table 10. Global Pet Medication Sale Price by Type (2018-2023) & (USD/MT)
Table 11. Global Pet Medication Sales by Application (2018-2023) & (K MT)
Table 12. Global Pet Medication Sales Market Share by Application (2018-2023)
Table 13. Global Pet Medication Revenue by Application (2018-2023)
Table 14. Global Pet Medication Revenue Market Share by Application (2018-2023)
Table 15. Global Pet Medication Sale Price by Application (2018-2023) & (USD/MT)
Table 16. Global Pet Medication Sales by Company (2018-2023) & (K MT)
Table 17. Global Pet Medication Sales Market Share by Company (2018-2023)
Table 18. Global Pet Medication Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Pet Medication Revenue Market Share by Company (2018-2023)
Table 20. Global Pet Medication Sale Price by Company (2018-2023) & (USD/MT)
Table 21. Key Manufacturers Pet Medication Producing Area Distribution and Sales Area
Table 22. Players Pet Medication Products Offered
Table 23. Pet Medication Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pet Medication Sales by Geographic Region (2018-2023) & (K MT)
Table 27. Global Pet Medication Sales Market Share Geographic Region (2018-2023)
Table 28. Global Pet Medication Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Pet Medication Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Pet Medication Sales by Country/Region (2018-2023) & (K MT)
Table 31. Global Pet Medication Sales Market Share by Country/Region (2018-2023)
Table 32. Global Pet Medication Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Pet Medication Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Pet Medication Sales by Country (2018-2023) & (K MT)
Table 35. Americas Pet Medication Sales Market Share by Country (2018-2023)
Table 36. Americas Pet Medication Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Pet Medication Revenue Market Share by Country (2018-2023)
Table 38. Americas Pet Medication Sales by Type (2018-2023) & (K MT)
Table 39. Americas Pet Medication Sales by Application (2018-2023) & (K MT)
Table 40. APAC Pet Medication Sales by Region (2018-2023) & (K MT)
Table 41. APAC Pet Medication Sales Market Share by Region (2018-2023)
Table 42. APAC Pet Medication Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Pet Medication Revenue Market Share by Region (2018-2023)
Table 44. APAC Pet Medication Sales by Type (2018-2023) & (K MT)
Table 45. APAC Pet Medication Sales by Application (2018-2023) & (K MT)
Table 46. Europe Pet Medication Sales by Country (2018-2023) & (K MT)
Table 47. Europe Pet Medication Sales Market Share by Country (2018-2023)
Table 48. Europe Pet Medication Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Pet Medication Revenue Market Share by Country (2018-2023)
Table 50. Europe Pet Medication Sales by Type (2018-2023) & (K MT)
Table 51. Europe Pet Medication Sales by Application (2018-2023) & (K MT)
Table 52. Middle East & Africa Pet Medication Sales by Country (2018-2023) & (K MT)
Table 53. Middle East & Africa Pet Medication Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Pet Medication Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Pet Medication Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pet Medication Sales by Type (2018-2023) & (K MT)
Table 57. Middle East & Africa Pet Medication Sales by Application (2018-2023) & (K MT)
Table 58. Key Market Drivers & Growth Opportunities of Pet Medication
Table 59. Key Market Challenges & Risks of Pet Medication
Table 60. Key Industry Trends of Pet Medication
Table 61. Pet Medication Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Pet Medication Distributors List
Table 64. Pet Medication Customer List
Table 65. Global Pet Medication Sales Forecast by Region (2024-2029) & (K MT)
Table 66. Global Pet Medication Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Pet Medication Sales Forecast by Country (2024-2029) & (K MT)
Table 68. Americas Pet Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Pet Medication Sales Forecast by Region (2024-2029) & (K MT)
Table 70. APAC Pet Medication Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Pet Medication Sales Forecast by Country (2024-2029) & (K MT)
Table 72. Europe Pet Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Pet Medication Sales Forecast by Country (2024-2029) & (K MT)
Table 74. Middle East & Africa Pet Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Pet Medication Sales Forecast by Type (2024-2029) & (K MT)
Table 76. Global Pet Medication Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Pet Medication Sales Forecast by Application (2024-2029) & (K MT)
Table 78. Global Pet Medication Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Zoetis Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 80. Zoetis Pet Medication Product Portfolios and Specifications
Table 81. Zoetis Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Zoetis Main Business
Table 83. Zoetis Latest Developments
Table 84. Merck Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Pet Medication Product Portfolios and Specifications
Table 86. Merck Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Elanco Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 90. Elanco Pet Medication Product Portfolios and Specifications
Table 91. Elanco Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Elanco Main Business
Table 93. Elanco Latest Developments
Table 94. Bayer Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer Pet Medication Product Portfolios and Specifications
Table 96. Bayer Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Bayer Main Business
Table 98. Bayer Latest Developments
Table 99. Boehringer Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 100. Boehringer Pet Medication Product Portfolios and Specifications
Table 101. Boehringer Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Boehringer Main Business
Table 103. Boehringer Latest Developments
Table 104. Novartis Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 105. Novartis Pet Medication Product Portfolios and Specifications
Table 106. Novartis Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Novartis Main Business
Table 108. Novartis Latest Developments
Table 109. Virbac Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 110. Virbac Pet Medication Product Portfolios and Specifications
Table 111. Virbac Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Virbac Main Business
Table 113. Virbac Latest Developments
Table 114. Ceva Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 115. Ceva Pet Medication Product Portfolios and Specifications
Table 116. Ceva Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Ceva Main Business
Table 118. Ceva Latest Developments
Table 119. Vetoquinol Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 120. Vetoquinol Pet Medication Product Portfolios and Specifications
Table 121. Vetoquinol Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Vetoquinol Main Business
Table 123. Vetoquinol Latest Developments
Table 124. Nexvet Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 125. Nexvet Pet Medication Product Portfolios and Specifications
Table 126. Nexvet Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. Nexvet Main Business
Table 128. Nexvet Latest Developments
Table 129. Aratana Therapeutics Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 130. Aratana Therapeutics Pet Medication Product Portfolios and Specifications
Table 131. Aratana Therapeutics Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 132. Aratana Therapeutics Main Business
Table 133. Aratana Therapeutics Latest Developments
Table 134. Kindred Biosciences Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 135. Kindred Biosciences Pet Medication Product Portfolios and Specifications
Table 136. Kindred Biosciences Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 137. Kindred Biosciences Main Business
Table 138. Kindred Biosciences Latest Developments
Table 139. Ambrx Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 140. Ambrx Pet Medication Product Portfolios and Specifications
Table 141. Ambrx Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 142. Ambrx Main Business
Table 143. Ambrx Latest Developments
Table 144. Entest Biomedical Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 145. Entest Biomedical Pet Medication Product Portfolios and Specifications
Table 146. Entest Biomedical Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 147. Entest Biomedical Main Business
Table 148. Entest Biomedical Latest Developments
Table 149. Taconic Biosciences Basic Information, Pet Medication Manufacturing Base, Sales Area and Its Competitors
Table 150. Taconic Biosciences Pet Medication Product Portfolios and Specifications
Table 151. Taconic Biosciences Pet Medication Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 152. Taconic Biosciences Main Business
Table 153. Taconic Biosciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pet Medication
Figure 2. Pet Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Medication Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Pet Medication Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pet Medication Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Antibiotics
Figure 10. Product Picture of Antifungal
Figure 11. Product Picture of Flea Products
Figure 12. Global Pet Medication Sales Market Share by Type in 2022
Figure 13. Global Pet Medication Revenue Market Share by Type (2018-2023)
Figure 14. Pet Medication Consumed in Cat
Figure 15. Global Pet Medication Market: Cat (2018-2023) & (K MT)
Figure 16. Pet Medication Consumed in Dog
Figure 17. Global Pet Medication Market: Dog (2018-2023) & (K MT)
Figure 18. Pet Medication Consumed in Horse
Figure 19. Global Pet Medication Market: Horse (2018-2023) & (K MT)
Figure 20. Pet Medication Consumed in Fish
Figure 21. Global Pet Medication Market: Fish (2018-2023) & (K MT)
Figure 22. Pet Medication Consumed in Others
Figure 23. Global Pet Medication Market: Others (2018-2023) & (K MT)
Figure 24. Global Pet Medication Sales Market Share by Application (2022)
Figure 25. Global Pet Medication Revenue Market Share by Application in 2022
Figure 26. Pet Medication Sales Market by Company in 2022 (K MT)
Figure 27. Global Pet Medication Sales Market Share by Company in 2022
Figure 28. Pet Medication Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Pet Medication Revenue Market Share by Company in 2022
Figure 30. Global Pet Medication Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Pet Medication Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Pet Medication Sales 2018-2023 (K MT)
Figure 33. Americas Pet Medication Revenue 2018-2023 ($ Millions)
Figure 34. APAC Pet Medication Sales 2018-2023 (K MT)
Figure 35. APAC Pet Medication Revenue 2018-2023 ($ Millions)
Figure 36. Europe Pet Medication Sales 2018-2023 (K MT)
Figure 37. Europe Pet Medication Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Pet Medication Sales 2018-2023 (K MT)
Figure 39. Middle East & Africa Pet Medication Revenue 2018-2023 ($ Millions)
Figure 40. Americas Pet Medication Sales Market Share by Country in 2022
Figure 41. Americas Pet Medication Revenue Market Share by Country in 2022
Figure 42. Americas Pet Medication Sales Market Share by Type (2018-2023)
Figure 43. Americas Pet Medication Sales Market Share by Application (2018-2023)
Figure 44. United States Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Pet Medication Sales Market Share by Region in 2022
Figure 49. APAC Pet Medication Revenue Market Share by Regions in 2022
Figure 50. APAC Pet Medication Sales Market Share by Type (2018-2023)
Figure 51. APAC Pet Medication Sales Market Share by Application (2018-2023)
Figure 52. China Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Pet Medication Sales Market Share by Country in 2022
Figure 60. Europe Pet Medication Revenue Market Share by Country in 2022
Figure 61. Europe Pet Medication Sales Market Share by Type (2018-2023)
Figure 62. Europe Pet Medication Sales Market Share by Application (2018-2023)
Figure 63. Germany Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Pet Medication Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Pet Medication Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Pet Medication Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Pet Medication Sales Market Share by Application (2018-2023)
Figure 72. Egypt Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Pet Medication in 2022
Figure 78. Manufacturing Process Analysis of Pet Medication
Figure 79. Industry Chain Structure of Pet Medication
Figure 80. Channels of Distribution
Figure 81. Global Pet Medication Sales Market Forecast by Region (2024-2029)
Figure 82. Global Pet Medication Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Pet Medication Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Pet Medication Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Pet Medication Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Pet Medication Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pet Medication
Figure 2. Pet Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Medication Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Pet Medication Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pet Medication Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Antibiotics
Figure 10. Product Picture of Antifungal
Figure 11. Product Picture of Flea Products
Figure 12. Global Pet Medication Sales Market Share by Type in 2022
Figure 13. Global Pet Medication Revenue Market Share by Type (2018-2023)
Figure 14. Pet Medication Consumed in Cat
Figure 15. Global Pet Medication Market: Cat (2018-2023) & (K MT)
Figure 16. Pet Medication Consumed in Dog
Figure 17. Global Pet Medication Market: Dog (2018-2023) & (K MT)
Figure 18. Pet Medication Consumed in Horse
Figure 19. Global Pet Medication Market: Horse (2018-2023) & (K MT)
Figure 20. Pet Medication Consumed in Fish
Figure 21. Global Pet Medication Market: Fish (2018-2023) & (K MT)
Figure 22. Pet Medication Consumed in Others
Figure 23. Global Pet Medication Market: Others (2018-2023) & (K MT)
Figure 24. Global Pet Medication Sales Market Share by Application (2022)
Figure 25. Global Pet Medication Revenue Market Share by Application in 2022
Figure 26. Pet Medication Sales Market by Company in 2022 (K MT)
Figure 27. Global Pet Medication Sales Market Share by Company in 2022
Figure 28. Pet Medication Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Pet Medication Revenue Market Share by Company in 2022
Figure 30. Global Pet Medication Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Pet Medication Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Pet Medication Sales 2018-2023 (K MT)
Figure 33. Americas Pet Medication Revenue 2018-2023 ($ Millions)
Figure 34. APAC Pet Medication Sales 2018-2023 (K MT)
Figure 35. APAC Pet Medication Revenue 2018-2023 ($ Millions)
Figure 36. Europe Pet Medication Sales 2018-2023 (K MT)
Figure 37. Europe Pet Medication Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Pet Medication Sales 2018-2023 (K MT)
Figure 39. Middle East & Africa Pet Medication Revenue 2018-2023 ($ Millions)
Figure 40. Americas Pet Medication Sales Market Share by Country in 2022
Figure 41. Americas Pet Medication Revenue Market Share by Country in 2022
Figure 42. Americas Pet Medication Sales Market Share by Type (2018-2023)
Figure 43. Americas Pet Medication Sales Market Share by Application (2018-2023)
Figure 44. United States Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Pet Medication Sales Market Share by Region in 2022
Figure 49. APAC Pet Medication Revenue Market Share by Regions in 2022
Figure 50. APAC Pet Medication Sales Market Share by Type (2018-2023)
Figure 51. APAC Pet Medication Sales Market Share by Application (2018-2023)
Figure 52. China Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Pet Medication Sales Market Share by Country in 2022
Figure 60. Europe Pet Medication Revenue Market Share by Country in 2022
Figure 61. Europe Pet Medication Sales Market Share by Type (2018-2023)
Figure 62. Europe Pet Medication Sales Market Share by Application (2018-2023)
Figure 63. Germany Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Pet Medication Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Pet Medication Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Pet Medication Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Pet Medication Sales Market Share by Application (2018-2023)
Figure 72. Egypt Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Pet Medication Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Pet Medication in 2022
Figure 78. Manufacturing Process Analysis of Pet Medication
Figure 79. Industry Chain Structure of Pet Medication
Figure 80. Channels of Distribution
Figure 81. Global Pet Medication Sales Market Forecast by Region (2024-2029)
Figure 82. Global Pet Medication Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Pet Medication Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Pet Medication Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Pet Medication Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Pet Medication Revenue Market Share Forecast by Application (2024-2029)
